From: Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Donor ID | Age | Sex | Primary path Dx | Additional Path Dx | A-beta (Thal) (1–5) | Braak stage (1–6) | Neuritic plaque (CERAD, Biel) | Diffuse plaque (CERAD, Biel) | Preparation |
---|---|---|---|---|---|---|---|---|---|
A1 | 89 | M | AD | LBD, TDP, HS, CVD, CAA | 5 | 6 | Frequent | Frequent | Cross section |
A2 | 82 | F | AD | CAA | 5 | 6 | Frequent | Frequent | Cross section |
A3 | 55 | F | AD | N/A | 5 | 6 | Frequent | Sparse | Cross section |
A4 | 84 | M | AD, CVD | N/A | 5 | 6 | Frequent | Moderate | Cross section |
A5 | 83 | M | DLB | Mild AD | 3 | 3 | Sparse | Sparse | Cross section |
A6 | 70 | M | AD | CAA | 5 | 6 | Moderate | Frequent | Punch |
A7 | 80 | M | DLB | Moderate AD | 3 | 4 | Moderate | Frequent | Punch |
A8 | 76 | F | AD | Mild HS | 5 | 6 | Frequent | Frequent | Punch |
A9 | 80 | M | AD | CAA, CVD | 5 | 6 | Frequent | Frequent | Cross section |
C1 | 80 | M | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C2 | 80 | N/A | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C3 | 72 | F | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C4 | 75 | M | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C5 | 75 | M | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C6 | 79 | M | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C7 | 75 | M | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C8 | 70 | M | Control | Control | N/A | N/A | N/A | N/A | Punch |
C9 | 68 | M | Control | Control | N/A | N/A | N/A | N/A | Punch |
C10 | 74 | M | Control | Control | N/A | N/A | N/A | N/A | Punch |
C11 | N/A | N/A | Control | Control | N/A | N/A | N/A | N/A | Cross section |
C12 | N/A | N/A | Control | Control | N/A | N/A | N/A | N/A | Cross section |